FHLC
Fidelity MSCI Health Care Index ETF·NYSE
--
--(--)
--
--(--)
Key Stats
Assets Under Management
2.95BUSD
Fund Flows (1Y)
-18.93MUSD
Dividend Yield
1.38%
Discount/Premium to NAV
-0.05%
Shares Outstanding
39.30M
Expense Ratio
0.08%
About Fidelity MSCI Health Care Index ETF
Issuer
Fidelity Management & Research Company LLC
Brand
Fidelity
Inception Date
Oct 21, 2013
Structure
Open-Ended Fund
Index Tracked
MSCI USA IMI Health Care Index
Management Style
Passive
Dividend Treatment
Distributes
Distribution Tax Treatment
Qualified dividends
Income Tax Type
Capital Gains
Max ST Capital Gains Rate
39.60%
Max LT Capital Gains Rate
20.00%
Primary Advisor
FMR Co., Inc.
Distributor
Fidelity Distributors Corp.
FHLC casts a wide net across the entire health care market in the US, capturing over 300 large-, mid- and small-cap companies and spanning more than 10 subsectors. This diversification gives the vanilla fund less exposure to the big pharma companies that dominate the market, and more exposure to sectors like drug retailers and insurance. Prior to December 1, 2020, the fund tracked the MSCI USA IMI Health Care Index, an uncapped version of the present index. To meet diversification requirements, FHLC now uses a 25/50 capping methodology. Notably, instead of replicating the underlying index, the fund uses a representative sampling strategy. The index is rebalanced quarterly.
Classification
Asset Class
Equity
Category
Sector
Focus
Health Care
Niche
Broad-based
Strategy
Vanilla
Geography
U.S.
Weighting Scheme
Market Cap
Selection Criteria
Market cap
Returns
1-Month | 3-Month | YTD | 1-Year | 3-Year | 5-Year | |
|---|---|---|---|---|---|---|
Price Performance | -1.25% | +7.06% | +1.18% | +6.73% | +18.78% | +24.32% |
NAV Total Return | -2.71% | +5.68% | -0.97% | +7.25% | +22.66% | +30.56% |
Ratings
No data is currently available
Ainvest’s AI-powered ETF Scoring Algorithm, built to help retail investors make smarter, data-driven decisions. Leveraging deep learning, reinforcement learning, and large language models, the algorithm scores ETFs across five key dimensions: Fund Flow, Momentum, Safety, Fundamentals, and Performance. Each factor is weighted by its correlation to future returns, resulting in a single, actionable score. Backtested over five years with consistently strong predictive accuracy. Ainvest brings institutional-grade artificial intelligence to everyday investors—transforming complexity into clarity with every score.
Holdings Analysis
Sector
Healthcare
99.98%
Financial Services
0.02%
Healthcare
99.98%
Financial Services
0.02%
Asset
Region
99.64%
0.33%
0.02%
0.01%
Category
Ratio
North America
99.64%
Europe
0.33%
Latin America
0.02%
Asia
0.01%
Investment Style
Mega
Large
Medium
Multi
Small
Value
Blend
Growth
Large-Cap Growth
Focuses on large-cap companies with high growth potential. These ETFs invest in leading companies with strong expansion prospects.
Top 10 Holdings
Symbol
Ratio
LLY
Eli Lilly
12.71%
JNJ
Johnson & Johnson
8.34%
ABBV
Abbvie
6.00%
MRK
Merck
4.20%
UNH
UnitedHealth Group
3.96%
TMO
Thermo Fisher
3.33%
ABT
Abbott Laboratories
2.90%
AMGN
Amgen
2.80%
ISRG
Intuitive Surgical
2.75%
GILD
Gilead Sciences
2.68%
Top 10 Weight 49.67%
317 Total Holdings
Is SPY better than FHLC?
Dividends
Dividend Payout History
Declaration Date | Record Date | Payment Date | Amount |
|---|---|---|---|
| 2025-09-19 | 2025-09-19 | 2025-09-23 | 0.256 |
| 2025-06-20 | 2025-06-20 | 2025-06-24 | 0.257 |
| 2025-03-21 | 2025-03-21 | 2025-03-25 | 0.252 |
| 2024-12-20 | 2024-12-20 | 2024-12-24 | 0.258 |
| 2024-09-20 | 2024-09-20 | 2024-09-24 | 0.250 |
| 2024-06-21 | 2024-06-21 | 2024-06-25 | 0.242 |
| 2024-03-15 | 2024-03-18 | 2024-03-20 | 0.238 |
Show more
How Much Does FHLC Pay in Dividends?
Premium/Discount Chart
Assets Under Management
Should I buy FHLC?
Fund Flows
